Skip to main content
DrugPrice

Nulojix

Belatacept

Generic availableTransplantby Bristol-Myers Squibb
$2,721.00
avg cost per claim
+8.6% year-over-year
$234.0M
Medicare Spending
86,000
Total Claims
9,600
Beneficiaries
$24,375.00
Annual Cost/Patient

Why Nulojix Costs $2,721.00 Per Claim

Nulojix (Belatacept) is used to treat transplant. According to CMS Medicare Part D spending data, the program spent $234.0M on this drug, covering 9,600 beneficiaries across 86,000 claims.

A generic version of this drug is available, which means lower-cost alternatives exist. Patients should ask their pharmacist about generic Belatacept or talk to their doctor about therapeutic alternatives that may cost less.

Price Breakdown

Avg cost per claim (30-day)$2,721.00
Avg annual cost per patient$24,375.00
Total Medicare spending$234.0M
Total claims86,000
Beneficiaries9,600

Drug Details

Brand Name
Nulojix
Generic Name
Belatacept
Active Ingredient
Belatacept
Manufacturer
Bristol-Myers Squibb
Dosage Form
N/A
Route
N/A
Condition
Transplant
FDA Application
BLA125057

Frequently Asked Questions

Nulojix (Belatacept) costs an average of $2,721.00 per claim based on Medicare Part D data. The estimated annual cost per patient is $24,375.00. Actual out-of-pocket costs depend on your insurance plan and pharmacy.

Yes, a generic version of Nulojix (Belatacept) is available. Generic medications typically cost 80-95% less than brand-name drugs. Ask your pharmacist about generic Belatacept.

Medicare Part D spent $234.0M on Nulojix, covering 9,600 beneficiaries across 86,000 claims. This makes it one of the tracked drugs in the Medicare spending dashboard.

Ask your pharmacist about generic Belatacept, which is typically much cheaper. You can also compare prices at different pharmacies, use prescription discount programs, or ask your doctor about therapeutic alternatives in the same drug class.

Cost data reflects Medicare Part D spending and may not represent retail pharmacy prices. Average cost per claim represents the total drug cost (not patient out-of-pocket) divided by total claims.